Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-10

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ovulatory dysfunction is identified in 15% of all infertile couples and it accounts for 40% of female infertility. Ovulatory dysfunction may be more subtle in women with regular menses. Detecting the day of ovulation is necessary for optimizing natural conception, diagnosis of cycle disturbances and also timing for embryo transfer in natural cycle frozen-thawed embryo transfers. In order to diagnose ovulatory dysfunction, ovulation physiology and change of reproductive hormones during the menstrual cycle should be understood. In the present study we aimed to evaluate serial serum hormonal cut-off levels referenced to ovulation in subfertile women with regular menses.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Progesterone Levels on Pregnancy

NCT04707430

Relationship of Progesterone Levels and Pregnancy

COMPLETED

Pregnancy Outcomes of Patients Having NC-FET Regarding the Progesterone Levels

NCT05690360

Infertility

UNKNOWN

Progesterone Levels During Ovulation and Luteal Phase

NCT05076981

Infertility, Female

COMPLETED

Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients

NCT02293668

Infertility

COMPLETED NA

The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates

NCT04128436

Luteal Phase Progesterone Levels

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subfertility, Female Ovulation Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

subfertile women

Subfertile women with regular menses (menstrual cycle length range from 21 to 35 days) will be examined by transvaginal ultrasonography at menstruation, before the anticipated date of ovulation and after ovulation. Serum hormone levels will be measured at menstruation, before ovulation and after ovulation with a serial manner.

Serum progesterone levels

Intervention Type DIAGNOSTIC_TEST

In order to show change of serum progesterone levels, serial venous blood sampling will be done and also transvaginal ultrasonography will be performed to show ovulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serum progesterone levels

In order to show change of serum progesterone levels, serial venous blood sampling will be done and also transvaginal ultrasonography will be performed to show ovulation.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women that have regular menses (menstrual cycle length 21-35 days)
* women who will come visits regularly
* women that are trying to conceive more than 1 year if women age is less than 35 years or more than 6 months if women age is \>35 years

Exclusion Criteria

* women who do not menstruate regularly
* women that use hormonal contraception
* women who take drugs that will interfere with steroid hormone metabolism

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No